Partner, BroadOak Capital Partners
Bill Snider is a Partner at BroadOak, where he leads the firm’s growth capital investing activities based on his more than 20 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC, a life sciences-focused venture capital firm. Prior to ETP he was a vice president and portfolio manager at T. Rowe Price, where his responsibilities included managing $2 billion of mutual fund and institutional client portfolios. Past directorships include Alpha Innotech, Molecular Transfer, and Atto Biosciences. He currently serves on a number of boards including Science and Medicine Group, Codex DNA, Halo Labs, IXRF Systems, antibodies-online, and Learning Undefeated, a non-profit organization that brings life-changing STEM education and career opportunities to underserved communities. Bill holds the Chartered Financial Analyst accreditation, and a BSE and MBA from the Wharton School at the University of Pennsylvania.